Cell Source (CLCS) Ratios
Cell Source Ratios
CLCS's free cash flow for Q4 2024 was $-748.33K. For the 2024 fiscal year, CLCS's free cash flow was decreased by $-4.00 and operating cash flow was $-748.33K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.02 | 0.02 | 0.01 | 0.03 | 0.03 |
| Quick Ratio | 0.02 | 0.02 | 0.01 | 0.03 | 0.03 |
| Cash Ratio | 0.02 | 0.00 | 0.00 | 0.02 | 0.01 |
| Solvency Ratio | -0.20 | -0.25 | -0.33 | -0.08 | -0.14 |
| Operating Cash Flow Ratio | -0.12 | -0.14 | -0.15 | -0.24 | -0.33 |
| Short-Term Operating Cash Flow Coverage | -0.21 | -0.27 | -0.25 | -0.40 | -0.52 |
| Net Current Asset Value | $ -22.46M | $ -18.80M | $ -15.61M | $ -12.63M | $ -9.83M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 27.97 | 35.14 | 47.42 | 19.29 | 20.62 |
| Debt-to-Equity Ratio | -0.58 | -0.54 | -0.59 | -0.63 | -0.66 |
| Debt-to-Capital Ratio | -1.37 | -1.15 | -1.46 | -1.67 | -1.93 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.02 | -0.02 | -0.01 | -0.03 | -0.03 |
| Debt Service Coverage Ratio | -0.18 | -0.32 | -0.41 | 0.00 | -0.01 |
| Interest Coverage Ratio | -1.34 | -3.29 | -4.12 | -4.21 | -2.95 |
| Debt to Market Cap | 0.48 | 0.69 | 0.64 | 0.27 | 0.18 |
| Interest Debt Per Share | 0.28 | 0.27 | 0.27 | 0.26 | 0.28 |
| Net Debt to EBITDA | -4.59 | -2.77 | -2.19 | 0.00 | -68.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 170.16% | 123.97% | 123.03% | 123.78% | 136.15% |
| Return on Assets (ROA) | -999.35% | -1665.29% | -2726.33% | -1260.96% | -1743.97% |
| Return on Equity (ROE) | 20.65% | 25.38% | 34.08% | 40.91% | 55.69% |
| Return on Capital Employed (ROCE) | 12.13% | 20.47% | 27.70% | 33.05% | 40.90% |
| Return on Invested Capital (ROIC) | 28.75% | 44.09% | -0.00% | 88.27% | 119.73% |
| Return on Tangible Assets | -999.35% | -1665.29% | -2726.33% | -1260.96% | -1743.97% |
| Earnings Yield | -17.06% | -32.56% | -37.06% | -17.45% | -15.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.06 | -0.06 | -0.09 | -0.12 |
| Free Cash Flow Per Share | -0.05 | -0.06 | -0.06 | -0.09 | -0.12 |
| Dividend Paid and CapEx Coverage Ratio | -682858.50 | 0.00 | 0.00 | -784671.50 | 0.00 |
| Capital Expenditure Coverage Ratio | -682858.50 | 0.00 | 0.00 | -784671.50 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.21 | -0.27 | -0.25 | -0.40 | -0.52 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -10.05% | -18.32% | -16.35% | -10.60% | -9.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.00 | -3.07 | -2.70 | -5.73 | -6.58 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -1.21 | -0.78 | -0.92 | -2.34 | -3.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.95 | -5.46 | -6.12 | -9.43 | -10.65 |
| Price-to-Operating Cash Flow Ratio | -9.95 | -5.46 | -6.12 | -9.43 | -10.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | 0.26 | 0.49 | 1.09 | 0.00 |
| Enterprise Value Multiple | -14.57 | -6.84 | -5.59 | 0.00 | -455.53 |
| Enterprise Value | 39.70M | 24.65M | 23.59M | 37.29M | 42.36M |
| EV to EBITDA | -14.57 | -6.84 | -5.59 | 0.00 | -455.53 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -14.53 | -9.18 | -10.05 | -11.88 | -12.54 |
| EV to Operating Cash Flow | -14.53 | -9.18 | -10.05 | -11.88 | -12.54 |
| Tangible Book Value Per Share | -0.41 | -0.45 | -0.41 | -0.36 | -0.35 |
| Shareholders’ Equity Per Share | -0.41 | -0.45 | -0.41 | -0.36 | -0.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.09 | -0.11 | -0.14 | -0.15 | -0.19 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.70 | 1.32 | 1.25 | 1.24 | 1.33 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.59 | 0.56 | 0.44 | 0.61 | 0.62 |
Currency in USD
